Logo image of CYB.MI

CYBEROO SPA (CYB.MI) Stock Fundamental Analysis

BIT:CYB - Euronext Milan - IT0005546103 - Common Stock - Currency: EUR

1.695  +0.02 (+1.19%)

Fundamental Rating

6

Taking everything into account, CYB scores 6 out of 10 in our fundamental rating. CYB was compared to 70 industry peers in the IT Services industry. While CYB has a great profitability rating, there are some minor concerns on its financial health. CYB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

In the past year CYB was profitable.
In the past year CYB had a positive cash flow from operations.
In the past 5 years CYB has always been profitable.
CYB had a positive operating cash flow in each of the past 5 years.
CYB.MI Yearly Net Income VS EBIT VS OCF VS FCFCYB.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M

1.2 Ratios

The Return On Assets of CYB (9.78%) is better than 94.67% of its industry peers.
Looking at the Return On Equity, with a value of 17.18%, CYB is in the better half of the industry, outperforming 77.33% of the companies in the same industry.
CYB's Return On Invested Capital of 14.15% is amongst the best of the industry. CYB outperforms 89.33% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CYB is in line with the industry average of 11.01%.
The last Return On Invested Capital (14.15%) for CYB is above the 3 year average (11.47%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.78%
ROE 17.18%
ROIC 14.15%
ROA(3y)7.43%
ROA(5y)5.45%
ROE(3y)13.09%
ROE(5y)9.28%
ROIC(3y)11.47%
ROIC(5y)8.38%
CYB.MI Yearly ROA, ROE, ROICCYB.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 17.25%, CYB belongs to the top of the industry, outperforming 97.33% of the companies in the same industry.
In the last couple of years the Profit Margin of CYB has grown nicely.
CYB has a Operating Margin of 26.38%. This is amongst the best in the industry. CYB outperforms 98.67% of its industry peers.
In the last couple of years the Operating Margin of CYB has grown nicely.
Looking at the Gross Margin, with a value of 72.96%, CYB is in the better half of the industry, outperforming 64.00% of the companies in the same industry.
CYB's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 26.38%
PM (TTM) 17.25%
GM 72.96%
OM growth 3Y107.49%
OM growth 5Y35.9%
PM growth 3Y164.24%
PM growth 5YN/A
GM growth 3Y3.49%
GM growth 5Y2.86%
CYB.MI Yearly Profit, Operating, Gross MarginsCYB.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CYB is creating some value.
The number of shares outstanding for CYB has been increased compared to 1 year ago.
Compared to 5 years ago, CYB has more shares outstanding
Compared to 1 year ago, CYB has a worse debt to assets ratio.
CYB.MI Yearly Shares OutstandingCYB.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
CYB.MI Yearly Total Debt VS Total AssetsCYB.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

An Altman-Z score of 4.19 indicates that CYB is not in any danger for bankruptcy at the moment.
CYB has a better Altman-Z score (4.19) than 89.33% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that CYB is not too dependend on debt financing.
The Debt to Equity ratio of CYB (0.24) is better than 68.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 4.19
ROIC/WACC1.72
WACC8.25%
CYB.MI Yearly LT Debt VS Equity VS FCFCYB.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 5M 10M 15M 20M

2.3 Liquidity

CYB has a Current Ratio of 2.31. This indicates that CYB is financially healthy and has no problem in meeting its short term obligations.
CYB has a better Current ratio (2.31) than 92.00% of its industry peers.
A Quick Ratio of 2.26 indicates that CYB has no problem at all paying its short term obligations.
CYB has a Quick ratio of 2.26. This is amongst the best in the industry. CYB outperforms 93.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 2.26
CYB.MI Yearly Current Assets VS Current LiabilitesCYB.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.23% over the past year.
Looking at the last year, CYB shows a very strong growth in Revenue. The Revenue has grown by 21.10%.
Measured over the past years, CYB shows a very strong growth in Revenue. The Revenue has been growing by 34.30% on average per year.
EPS 1Y (TTM)0.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.08%
Revenue 1Y (TTM)21.1%
Revenue growth 3Y52.98%
Revenue growth 5Y34.3%
Sales Q2Q%16.23%

3.2 Future

CYB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.26% yearly.
CYB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.74% yearly.
EPS Next Y-18.64%
EPS Next 2Y6.56%
EPS Next 3Y14.26%
EPS Next 5YN/A
Revenue Next Year9.09%
Revenue Next 2Y14.81%
Revenue Next 3Y16.74%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CYB.MI Yearly Revenue VS EstimatesCYB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
CYB.MI Yearly EPS VS EstimatesCYB.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.05 0.1 0.15

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

CYB is valuated rather expensively with a Price/Earnings ratio of 18.83.
Based on the Price/Earnings ratio, CYB is valued a bit cheaper than the industry average as 65.33% of the companies are valued more expensively.
CYB's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.35.
CYB is valuated correctly with a Price/Forward Earnings ratio of 12.52.
CYB's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CYB is cheaper than 76.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, CYB is valued a bit cheaper.
Industry RankSector Rank
PE 18.83
Fwd PE 12.52
CYB.MI Price Earnings VS Forward Price EarningsCYB.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CYB's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CYB is cheaper than 72.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.28
CYB.MI Per share dataCYB.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4 0.5

4.3 Compensation for Growth

CYB has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CYB's earnings are expected to grow with 14.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.56%
EPS Next 3Y14.26%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CYB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CYBEROO SPA

BIT:CYB (3/7/2025, 7:00:00 PM)

1.695

+0.02 (+1.19%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners19.17%
Inst Owner ChangeN/A
Ins Owners4%
Ins Owner ChangeN/A
Market Cap70.21M
Analysts45.71
Price Target3.26 (92.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-31.91%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4%
Valuation
Industry RankSector Rank
PE 18.83
Fwd PE 12.52
P/S 3.3
P/FCF N/A
P/OCF 35.04
P/B 3.29
P/tB 6.52
EV/EBITDA 6.28
EPS(TTM)0.09
EY5.31%
EPS(NY)0.14
Fwd EY7.98%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.05
OCFY2.85%
SpS0.51
BVpS0.52
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.78%
ROE 17.18%
ROCE 20.96%
ROIC 14.15%
ROICexc 17.81%
ROICexgc 34.79%
OM 26.38%
PM (TTM) 17.25%
GM 72.96%
FCFM N/A
ROA(3y)7.43%
ROA(5y)5.45%
ROE(3y)13.09%
ROE(5y)9.28%
ROIC(3y)11.47%
ROIC(5y)8.38%
ROICexc(3y)16.29%
ROICexc(5y)12.1%
ROICexgc(3y)40.18%
ROICexgc(5y)33.06%
ROCE(3y)17.7%
ROCE(5y)12.99%
ROICexcg growth 3Y148.5%
ROICexcg growth 5Y4.31%
ROICexc growth 3Y169.26%
ROICexc growth 5Y31.45%
OM growth 3Y107.49%
OM growth 5Y35.9%
PM growth 3Y164.24%
PM growth 5YN/A
GM growth 3Y3.49%
GM growth 5Y2.86%
F-Score3
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA 0.47
Cap/Depr 89.42%
Cap/Sales 22.76%
Interest Coverage 16.11
Cash Conversion 18.16%
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 2.26
Altman-Z 4.19
F-Score3
WACC8.25%
ROIC/WACC1.72
Cap/Depr(3y)106.07%
Cap/Depr(5y)163.22%
Cap/Sales(3y)28.01%
Cap/Sales(5y)42.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.08%
EPS Next Y-18.64%
EPS Next 2Y6.56%
EPS Next 3Y14.26%
EPS Next 5YN/A
Revenue 1Y (TTM)21.1%
Revenue growth 3Y52.98%
Revenue growth 5Y34.3%
Sales Q2Q%16.23%
Revenue Next Year9.09%
Revenue Next 2Y14.81%
Revenue Next 3Y16.74%
Revenue Next 5YN/A
EBIT growth 1Y6.24%
EBIT growth 3Y217.42%
EBIT growth 5Y82.52%
EBIT Next Year20%
EBIT Next 3Y23.86%
EBIT Next 5YN/A
FCF growth 1Y-190.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.34%
OCF growth 3Y53.59%
OCF growth 5YN/A